A federal jail with a documented history of power outages, staffing shortages and detainee complaints got two more ...

The bull case wasn't helped by an analyst's recommendation downgrade. That pundit now feels the biotech's shares only rate a ...

The problem with drug patents is that they end, leading to patent cliffs. That's when cheaper generic versions of a drug take ...

Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...

When is the right time to train a dog? EASTON, PA, UNITED STATES, January 5, 2026 /EINPresswire.com/ — When is the right time to train a dog? A recent HelloNation article featuring Pet Care Expert ...

PAI Pharma said the acquisition aligns with a growing national focus on reshoring pharmaceutical production, reducing ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract ...

What Happened? Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 3.8% in the afternoon session after ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...

Despite Trump’s efforts, the executive branch can only fix some of what’s wrong with our healthcare system. The power and ...